Trial NCT01093183

View at ClinicalTrials.gov 
Org. Study IDs: 0479-09-FB
Secondary IDs: 479-09 NCI-2010-00363 P30CA036727

Last trial update was posted on 2023-09-13

MeSH Interventions

Cyclophosphamide Lenalidomide

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer

Stopping Reasons

study sponsors withdrew support for the study drug.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID